{
  "report_rows": [
    {
      "kpi": "Organic net sales growth",
      "prediction": "BEAT",
      "answer": "pred ~-3.2% vs. cons -3.5%",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EBITDA",
      "prediction": "BEAT",
      "answer": "pred ~$1.30B vs. cons $1.28B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$0.54 vs. cons $0.53",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Organic net sales growth",
      "prediction": "BETTER",
      "answer": "guide ~-2.5% midpoint vs. cons -2.6% (FY2026)",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Adjusted EPS",
      "prediction": "UNCHANGED",
      "answer": "guide ~$2.04 midpoint vs. cons $2.05 (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Constant-currency adjusted operating income growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~-16.0% midpoint vs. cons -16.0% (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Adjusted gross margin change",
      "prediction": "BETTER",
      "answer": "guide ~-50 bps midpoint vs. cons -55 bps (FY2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 3.1,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 1.2,
  "day5_path": "FADE",
  "day5_rationale": "A modest Q2 operating beat should initially reward improving volume and share trends, but FY2026 adjusted EPS guidance of ~$2.04 midpoint vs. consensus $2.05 and constant-currency adjusted operating income growth of ~-16.0% vs. consensus -16.0% provide little upward-revision support; heavier second-half investment and inflation should pull the five-day residual below the day-one move.",
  "day5_confidence": "MEDIUM"
}